Capital Senior Living Corp (CSU) Fundamental Analysis & Valuation

NYSE:CSU

Current stock price

33.54
-0.72 (-2.09%)
Last:

This CSU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CSU Profitability Analysis

1.1 Basic Checks

  • In the past year CSU has reported negative net income.
CSU Yearly Net Income VS EBIT VS OCF VS FCFCSU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -21.75%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSU Yearly ROA, ROE, ROICCSU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 100 -100 -200

1.3 Margins

  • CSU does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) -49.97%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSU Yearly Profit, Operating, Gross MarginsCSU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CSU Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CSU remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for CSU is higher compared to a year ago.
CSU Yearly Shares OutstandingCSU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 500K 1M 1.5M 2M
CSU Yearly Total Debt VS Total AssetsCSU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 200M 400M 600M 800M 1B

2.2 Solvency

  • CSU has an Altman-Z score of -1.29. This is a bad value and indicates that CSU is not financially healthy and even has some risk of bankruptcy.
  • CSU has a Debt/Equity ratio of -2.98. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -2.98
Debt/FCF N/A
Altman-Z -1.29
ROIC/WACCN/A
WACCN/A
CSU Yearly LT Debt VS Equity VS FCFCSU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

  • CSU has a Current Ratio of 0.11. This is a bad value and indicates that CSU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CSU has a Quick Ratio of 0.11. This is a bad value and indicates that CSU is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
CSU Yearly Current Assets VS Current LiabilitesCSU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CSU Growth Analysis

3.1 Past

  • The earnings per share for CSU have decreased strongly by -169.26% in the last year.
  • Looking at the last year, CSU shows a very negative growth in Revenue. The Revenue has decreased by -30.87% in the last year.
  • The Revenue has been decreasing by -1.41% on average over the past years.
EPS 1Y (TTM)-169.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%472.86%
Revenue 1Y (TTM)-30.87%
Revenue growth 3Y-6.32%
Revenue growth 5Y-1.41%
Sales Q2Q%-43.31%

3.2 Future

  • Based on estimates for the next years, CSU will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.95% on average per year.
  • Based on estimates for the next years, CSU will show a decrease in Revenue. The Revenue will decrease by -3.59% on average per year.
EPS Next Y127.22%
EPS Next 2Y39.76%
EPS Next 3Y25.31%
EPS Next 5Y13.95%
Revenue Next Year-39.6%
Revenue Next 2Y-18.7%
Revenue Next 3Y-10.67%
Revenue Next 5Y-3.59%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSU Yearly Revenue VS EstimatesCSU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CSU Yearly EPS VS EstimatesCSU Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. CSU Valuation Analysis

4.1 Price/Earnings Ratio

  • CSU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CSU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSU Price Earnings VS Forward Price EarningsCSU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.81
CSU Per share dataCSU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CSU's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.76%
EPS Next 3Y25.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CSU Dividend Analysis

5.1 Amount

  • No dividends for CSU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CSU Fundamentals: All Metrics, Ratios and Statistics

Capital Senior Living Corp

NYSE:CSU (11/12/2021, 8:52:54 PM)

33.54

-0.72 (-2.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners127.24%
Ins Owner Change0%
Market Cap70.07M
Revenue(TTM)295.44M
Net Income(TTM)-147.62M
Analysts42.5
Price Target23.46 (-30.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 38.81
EPS(TTM)-72.7
EYN/A
EPS(NY)-5.77
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS141.43
BVpS-91.27
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -49.97%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity -2.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -1.29
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%472.86%
EPS Next Y127.22%
EPS Next 2Y39.76%
EPS Next 3Y25.31%
EPS Next 5Y13.95%
Revenue 1Y (TTM)-30.87%
Revenue growth 3Y-6.32%
Revenue growth 5Y-1.41%
Sales Q2Q%-43.31%
Revenue Next Year-39.6%
Revenue Next 2Y-18.7%
Revenue Next 3Y-10.67%
Revenue Next 5Y-3.59%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Capital Senior Living Corp / CSU Fundamental Analysis FAQ

What is the fundamental rating for CSU stock?

ChartMill assigns a fundamental rating of 1 / 10 to CSU.


What is the valuation status of Capital Senior Living Corp (CSU) stock?

ChartMill assigns a valuation rating of 0 / 10 to Capital Senior Living Corp (CSU). This can be considered as Overvalued.


How profitable is Capital Senior Living Corp (CSU) stock?

Capital Senior Living Corp (CSU) has a profitability rating of 1 / 10.


How financially healthy is Capital Senior Living Corp?

The financial health rating of Capital Senior Living Corp (CSU) is 2 / 10.


What is the expected EPS growth for Capital Senior Living Corp (CSU) stock?

The Earnings per Share (EPS) of Capital Senior Living Corp (CSU) is expected to grow by 127.22% in the next year.